News
Viva Biotech Upcoming Conferences and Events
Time: 2022-09-06
Source: Viva Biotech
Share:
[Abstract]:Viva Biotech will attend four industry conferences and events in the coming months. 

CMC-China 2022

 

 

On September 7-8, CMC-China 2022 will be held in Suzhou. The conference will focus on the latest international and domestic biopharmaceutical news, covering topics such as antibody drugs, nucleic acid drugs, complex formulations, and APIs.
On September 8, Dr. Han Dai, CIO of Viva Biotech and Head of Viva BioInnovator, will join the Innovative Drug Development Forum II as one of the panelists on "How to Determine and Solve the Unmet Clinical Drug Needs" .
Langhua will be at booth No. 49 and welcomes guests for face-to-face meetings.

 

 

BIT 2022

 

On September 8-9, BIT 2022 Summit will be held in Shanghai, where industry experts on antibody drugs and colleagues will gather to discuss the current trends in antibody drug R&D.

 


On September 9, Dr. Han Dai, CIO of Viva Biotech and Head of Viva BioInnovator, will join the summit as a panelist on "The Progress of Innovative Drug R&D for Local Pharmaceutical Companies" .

 

 

2022 World Bio-Industry Congress & Expo


On September 21-23, the 2022 World Bio-Industry Congress & Expo will be held in Dalian. With the theme of "Innovation, Leadership, and Development," the conference will be driven by discussions on technology and investment cooperation. It will aim at increasing awareness of all things biomedical on a global scale, supporting national, provincial, and municipal planning, and promoting the overall development of biomedicine within China. 

 


Dr. Han Dai, CIO of Viva Biotech and Head of Viva BioInnovator, will share his insights at the forum on "Beyond Small Molecule Medicinal Chemistry: New Opportunities for PROTAC Induced Protein Degradation".

 

 

BIOLIGN Innovators World-China 2022

 

On September 28-29, the BIOLIGN Innovators World-China 2022 Conference will be held in Nanjing, where experts from all walks of life will gather to discuss the development strategies for the next decade.

 


On September 29, Dr. Han Dai, CIO of Viva Biotech and Head of Viva BioInnovator, will attend the conference in Session C - Panel 7 that focuses on "Eplorixng Source Innovation from Small Molecule Drugs and Biotech Therapies" with the guests.

Media contact: vivapr@vivabiotech.com
Contact Us